Research & Development
Our Aim
The primary aim of Berand is to identify and develop novel and effective drugs for use in the treatment of brain illness. At the heart of our approach to drug development is an in-depth understanding of the mechanisms that contribute to the emergence of brain disease and the identification of drugs that facilitate the adaptive ability of the brain (neuroplasticity) to overcome disease onset. Such gradually developing adaptations in nerve circuits explain how currently available treatments for mental illnesses, such as depression and schizophrenia, take weeks or even months to exert their actions. To date, Berand has filed patents, one with the potential to treat autism and one for obesity.